|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/712 | |||
| A61K 31/7125 | |||
| A61K 31/7115 |
| (11) | Number of the document | 3310918 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16742444.9 |
| Date of filing the European patent application | 2016-06-15 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/037563 |
| Date | 2016-06-15 |
| (87) | Number | WO 2016/205323 |
| Date | 2016-12-22 |
| (30) | Number | Date | Country code |
| 201562181602 P | 2015-06-18 | US |
| (72) |
HINKLE, Gregory, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF |
| POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF |